Liquid chromatography-mass spectrometry in in vitro drug metabolite screening

Drug Discovery Today

Volumn 14, Issue 3-4, 2009, Pages 120-133

  Tolonen, Ari ^a   Turpeinen, Miia ^b,c,d   Pelkonen, Olavi ^d  

^a Novamass Analytical Ltd   (Finland)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE;

ANALYTIC METHOD; BIOTRANSFORMATION; DATA EXTRACTION; DRUG METABOLISM; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSTRUMENTATION; MASS SPECTROMETER; MASS SPECTROMETRY; REVIEW;

BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DISCOVERY; HUMANS; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 58849124556     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.11.002     Document Type: Review

References (102)

1. Pelkonen O., et al. Prediction of drug metabolism and interactions on the basis of in vitro investigations. Basic Clin. Pharmacol. Toxicol. 96 (2005) 67-175
2. Coecke S., et al. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. Altern. Lab. Anim. 34 (2006) 49-84
3. Eddershaw P.J., et al. ADME/PK as part of a rational approach to drug discovery. Drug Discov. Today 5 (2000) 409-414
4. Roberts S.A. Drug metabolism and pharmacokinetics in drug discovery. Curr. Opin. Drug Discov. Dev. 6 (2003) 66-80
5. Lee M.S., and Kerns E.H. LC/MS applications in drug development. Mass Spectrom. Rev. 18 (1999) 187-279
6. Kostiainen R., et al. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies. J. Mass Spectrom. 38 (2003) 357-372
7. Cech N.B., and Enke C.G. Practical implications of some recent studies in electrospray ionization fundamentals. Mass Spectrom. Rev. 20 (2001) 362-387
8. Cole M.J., et al. Electrospray mass spectrometry in contemporary drug metabolism and pharmacokinetics. In: Pramanik B.N., Ganguly A.K., and Gross M.L. (Eds). Applied Electrospray Mass Spectrometry (2002), Marcel Dekker Inc. 211-249
9. Horning E.C., et al. New picogram detection system based on a mass spectrometer with an external ionization source at atmospheric pressure. Anal. Chem. 45 (1973) 936-943
10. Leinonen A., et al. Liquid chromatography/mass spectrometry in anabolic steroid analysis - optimization and comparison of three ionization techniques: electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization. J. Mass Spectrom. 37 (2002) 693-698
11. Robb D.B., et al. Atmospheric pressure photoionization: an ionization method for liquid chromatography-mass spectrometry. Anal. Chem. 72 (2000) 3653-3659
12. Cai Y., et al. Advantages of atmospheric pressure photoionization mass spectrometry in support of drug discovery. Rapid Commun. Mass Spectrom. 19 (2005) 1717-1724
13. Pelkonen O., and Turpeinen M. In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica 37 (2007) 1066-1089
14. Ding X., and Kaminsky L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Ann. Rev. Pharmacol. Toxicol. 43 (2003) 149-173
15. Briem S., et al. Combined approach for high-throughput preparation and analysis of plasma samples from exposure studies. Rapid Commun. Mass Spectrom. 21 (2007) 1965-1972
16. Chang M.S., et al. Evaluation of 384-well formatted sample preparation technologies for regulated bioanalysis. Rapid Commun. Mass Spectrom. 21 (2007) 64-72
17. Tsai T.T. Assaying protein unbound drugs using microdialysis techniques. J. Chromatogr. B 797 (2003) 161-173
18. Tang Y., et al. Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography. Biomed. Chromatogr. 20 (2006) 1116-1119
19. Waters N.J., et al. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J. Pharm. Sci. 97 (2008) 4586-4595
20. Chen Y., et al. Analytical tools and approaches for metabolite identification in early drug discovery. Pharm. Res. 24 (2007) 248-257
21. Prakash C., et al. Analytical strategies for identifying drug metabolites. Mass Spectrom. Rev. 26 (2007) 340-369
22. Churchwell M.I., et al. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B 825 (2005) 134-143
23. Yu K., et al. High-throughput quantification for a drug mixture in rat plasma - a comparison of Ultra PerformanceTM liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20 (2006) 544-552
24. Pedraglio S., et al. New perspectives in bio-analytical techniques for preclinical characterization of a drug candidate: UPLC-MS/MS in in vitro metabolism and pharmacokinetic studies. J. Pharm. Biomed. Anal. 44 (2007) 665-667
25. Yoshida T., and Majors R.E. High-speed analyses using rapid resolution liquid chromatography on 1.8-μm porous particles. J. Sep. Sci. 29 (2006) 2421-2432
26. Mortishire-Smith R.J., et al. Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis. Rapid Commun. Mass Spectrom. 19 (2005) 2659-2670
27. Tiller P.R., et al. High-throughput, accurate mass liquid chromatography/tandem mass spectrometry on a quadrupole time-of-flight system as a 'first-line' approach for metabolite identification studies. Rapid Commun. Mass Spectrom. 22 (2008) 1053-1061
28. Hakala K.S., et al. Feasibility of different mass spectrometric techniques and programs for automated metabolite profiling of tramadol in human urine. Rapid Commun. Mass Spectrom. 20 (2006) 1-10
29. Anari M.R., et al. Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: application to studies on the biotransformation of indinavir. Anal. Chem. 76 (2004) 823
30. Zhang H., et al. An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine. J. Mass Spectrom. 43 (2008) 1191-1200
31. Zhang N., et al. Quantification and rapid metabolite identification in drug discovery using API time-of-flight LC/MS. Anal. Chem. 72 (2000) 800-806
32. Plumb R.S., et al. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun. Mass Spectrom. 17 (2003) 2632-2638
33. Hu Q., et al. The Orbitrap: a new mass spectrometer. J. Mass Spectrom. 40 (2005) 430-443
34. Lim H.K., et al. Metabolite identification by data-dependent accurate mass spectrometric analysis at resolving power of 60 000 in external calibration mode using an LTQ/Orbitrap. Rapid Commun. Mass Spectrom. 21 (2007) 1821-1832
35. Zhu M., et al. Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering. Anal. Chem. 79 (2007) 8333-8341
36. Kantharaj E., et al. Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry. Rapid Commun. Mass Spectrom. 17 (2003) 2661-2668
37. Hopfgartner G., et al. Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer. J. Mass Spectrom. 38 (2003) 138-150
38. Castro-Perez J., et al. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 19 (2005) 843-848
39. E with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun. Mass Spectrom. 21 (2007) 1485-1496
40. Wrona M., et al. All-in-One' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. Rapid Commun. Mass Spectrom. 19 (2005) 2597-2602
41. Zhang H., et al. A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses. J. Mass Spectrom. 38 (2003) 1110-1112
42. Zhu M.S., et al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug Metab. Dispos. 34 (2006) 1722-1733
43. Liu D.Q., et al. On-line H/D exchange LC-MS strategy for structural elucidation of pharmaceutical impurities. J. Pharm. Biomed. Anal. 44 (2007) 320-329
44. Nassar A.E.F. Online hydrogen-deuterium exchange and a tandem-quadrupole time-of-flight mass spectrometer coupled with liquid chromatography for metabolite identification in drug metabolism. J. Chromatogr. Sci. 41 (2003) 398-404
45. Liu D.Q., and Hop C.E. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches. J. Pharm. Biomed. Anal. 37 (2005) 1-18
46. Tolonen A., et al. A simple method for differentiation of monoisotopic drug metabolites with hydrogen-deuterium exchange liquid chromatography/electrospray mass spectrometry. Eur. J. Pharm. Sci. 25 (2005) 155-162
47. Pfeifer T., et al. Structural characterization of sulfadiazine metabolites using H/D exchange combined with various MS/MS experiments. J. Am. Soc. Mass Spectrom. 16 (2005) 1687-1694
48. Peiris D.M., et al. Distinguishing N-oxide and hydroxyl compounds: impact of heated capillary/heated ion transfer tube in inducing atmospheric pressure ionization source decompositions. J. Mass Spectrom. 39 (2004) 600-606
49. Ramanathan R., et al. Liquid chromatography/mass spectrometry methods for distinguishing N-oxides from hydroxylated compounds. Anal. Chem. 72 (2000) 1352-1359
50. Gunaratna C., and Zhang T. Application of liquid chromatography-electrospray ionization-ion trap mass spectrometry to investigate the metabolism of silibinin in human liver microsomes. J. Chromatogr. B 794 (2003) 303-310
51. Hopfgartner G., et al. Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules. J. Mass Spectrom. 39 (2004) 845-855
52. Xia Y.Q., et al. Use of a quadrupole-linear ion trap-mass spectrometer in metabolite identification and bioanalysis. Rapid Commun. Mass Spectrom. 17 (2003) 1137-1145
53. Li A.C., et al. Complete profiling and characterization of in vitro nefazodone metabolites using two different tandem mass spectrometric platforms. Rapid Commun. Mass Spectrom. 21 (2007) 4001-4008
54. Mutlib A., et al. Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites. Rapid Commun. Mass Spectrom. 19 (2005) 3482-3492
55. Ma L., et al. Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and postacquisition data mining. Chem. Res. Toxicol. 21 (2008) 1477-1483
56. Decaestecker T.N., et al. Evaluation of automated single mass spectrometry to tandem mass spectrometry function switching for comprehensive drug profiling analysis using a quadrupole time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 14 (2000) 1787-1792
57. Kamel A., and Prakash C. High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology studies. Curr. Drug Metab. 7 (2006) 828-843
58. Riley R.J., et al. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Drug Metab. Dispos. 33 (2005) 1304-1311
59. Janiszewski J.S., et al. A high-capacity LC/MS system for the bioanalysis of samples generated from plate based metabolic screening. Anal. Chem. 73 (2004) 1495-1501
60. Wring S.A., et al. Automated quantitative and qualitative analysis of metabolic stability: a process for compound selection during drug discovery. Methods Enzymol. 357 (2002) 285-295
61. Jenkins K.M., et al. Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries. J. Pharm. Biomed. Anal. 34 (2004) 989-1004
62. Chovan L.E., et al. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays. Rapid Commun. Mass Spectrom. 18 (2004) 3105-3112
63. Tong X.S., et al. High throughput metabolic stability screen for lead optimization in drug discovery. J. Chromatogr. B 833 (2006) 165-173
64. Gu M., and Lim H.K. An intelligent data acquisition system for simultaneous screening of microsomal stability and metabolite profiling by liquid chromatography/mass spectrometry. J. Mass Spectrom. 36 (2001) 1053-1061
65. Tiller P.R., and Romanyshyn L.A. Liquid chromatography/tandem mass spectrometric quantification with metabolite screening as a strategy to enhance the early drug discovery process. Rapid Commun. Mass Spectrom. 16 (2002) 1225-1231
66. O'Connor D., et al. Ultra-performance liquid chromatography coupled to time-of-flight mass spectrometry for robust, high-throughput quantitative analysis of an automated metabolic stability assay, with simultaneous determination of metabolic data. Rapid Commun. Mass Spectrom. 20 (2006) 851-857
67. Guengerich F.P. Principles of covalent binding of reactive metabolites and examples of activation of bis-electrophiles by conjugation. Arch. Biochem. Biophys. 433 (2005) 369-378
68. Guengerich F.P., and MacDonald J.S. Applying mechanisms of chemical toxicity to predict drug safety. Chem. Res. Toxicol. 20 (2007) 344-369
69. Baillie T.A. Future of toxicology: metabolic activation and drug design: challenges and opportunities in chemical toxicology. Chem. Res. Toxicol. 19 (2006) 889-893
70. Stevens J.L. Future of toxicology: mechanisms of toxicity and drug safety: where do we go from here?. Chem. Res. Toxicol. 19 (2006) 1393-1401
71. Ma S., and Subramanian R. Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 41 (2006) 1121-1139
72. Baillie T.A., and Davis M.R. Mass spectrometry in the analysis of glutathione conjugates. Biol. Mass Spectrom. 22 (1993) 319-325
73. Dieckhaus C.M., et al. Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chem. Res. Toxicol. 18 (2005) 630-638
74. Yan Z., and Caldwell G.W. Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature. Anal. Chem. 76 (2004) 6835-6847
75. Yan Z., et al. Rapid detection and characterization of minor reactive metabolites using stable-isotope trapping in combination with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19 (2005) 3322-3330
76. Gan J., et al. Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites. Chem. Res. Toxicol. 18 (2005) 896-903
77. Soglia J.R., et al. The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent. J. Pharm. Biomed. Anal. 36 (2004) 105-116
78. Soglia J.R., et al. A semiquantitative method for the determination of reactive metabolite conjugate levels in vitro utilizing liquid chromatography-tandem mass spectrometry and novel quaternary ammonium glutathione analogues. Chem. Res. Toxicol. 19 (2006) 480-490
79. Wen B., et al. High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry. Anal. Chem. 80 (2008) 1788-1799
80. Castro-Perez J., et al. A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. Rapid Commun. Mass Spectrom. 19 (2005) 798-804
81. Zhang K.E., et al. Microsomal metabolism of the 5-lipoxygenase inhibitor L-739. Chem. Res. Toxicol. 9 (1996) 547-554
82. Xu S., et al. Metabolic activation of fluorpyrrolidine dipeptidyl peptidase-IV inhibitors by rat liver microsomes. Drug Metab. Dispos. 33 (2005) 121-130
83. Argoti D., et al. Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Chem. Res. Toxicol. 18 (2005) 1537-1544
84. Yan Z., et al. Use of a trapping agent for simultaneous capturing and high-throughput screening of both "soft" and "hard" reactive metabolites. Anal. Chem. 79 (2007) 4206-4214
85. Mitchell M.D., et al. Peptide-based in vitro assay for detection of reactive metabolites. Chem. Res. Toxicol. 21 (2008) 859-868
86. Hop C.E., et al. In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 16 (2002) 212-219
87. Kerns E.H., et al. Integrated high capacity solid phase extraction-MS/MS system for pharmaceutical profiling in drug discovery. J. Pharm. Biomed. Anal. 34 (2004) 1-9
88. Inman B.L., et al. Solid phase extraction as a faster alternative to HPLC: application to MS analysis of metabolic stability samples. J. Pharm. Sci. 96 (2007) 1619-1624
89. Nägele E., and Fandino A.S. Simultaneous determination of metabolic stability and identification of buspirone metabolites using multiple column fast liquid chromatography time-of-flight mass spectrometry. J. Chromatogr. A 1156 (2007) 196-200
90. Lhöest G.J.J., et al. Isolation, identification and immunosuppressive activity of a new IMM-125 metabolite from human liver microsomes. Identification of its cyclophilin A-IMM-125 metabolite complex by nanospray tandem mass spectrometry. J. Mass Spectrom. 33 (1998) 936-942
91. Valaskovic G.A., et al. Ultra-low flow nanospray for the normalization of liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery. Rapid Commun. Mass Spectrom. 20 (2006) 1087-1096
92. Yin F., and Killeen K. The fundamental aspects and applications of Agilent HPLC-chip. J. Sep. Sci. 30 (2007) 1427-1434
93. Sikanen T., et al. Fully Microfabricated and integrated SU-8-based capillary electrophoresis-electrospray ionization microchips for mass spectrometry. Anal. Chem. 79 (2007) 9135-9144
94. Huikko K., et al. Introduction to micro-analytical systems: bioanalytical and pharmaceutical applications. Eur. J. Pharm. Sci. 20 (2003) 149-171
95. Takats Z., et al. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306 (2004) 471-473
96. Takats Z., et al. Ambient mass spectrometry using desorption electrospray ionization (DESI): instrumentation, mechanisms and applications in forensics, chemistry, and biology. J. Mass Spectrom. 40 (2005) 1261-1275
97. Takats Z., et al. Direct, trace level detection of explosives on ambient surfaces by desorption electrospray ionization mass spectrometry. Chem. Commun. 15 (2005) 1950-1952
98. Haddad R., et al. Desorption sonic spray ionization for (high) voltage-free ambient mass spectrometry. Rapid Commun. Mass Spectrom. 20 (2006) 2901-2905
99. Haapala M., et al. Desorption atmospheric pressure photoionization. Anal. Chem. 79 (2007) 7867-7872
100. Williams J.P., et al. The use of recently described ionisation techniques for the rapid analysis of some common drugs and samples of biological origin. Rapid Commun. Mass Spectrom. 20 (2006) 1447-1456
101. Kauppila T.J., et al. Desorption electrospray ionization mass spectrometry for the analysis of pharmaceuticals and metabolites. Rapid Commun. Mass Spectrom. 20 (2006) 387-392
102. Kauppila T.J., et al. Direct analysis of illicit drugs by desorption atmospheric pressure photoionization. Rapid Commun. Mass Spectrom. 22 (2008) 979-985